eccogene glp 1 Elecoglipron Shows Positive Results in Phase 1b Trial in China | posted on the topic GLP-1s & Beyond: Understanding Incretin
Description
Thats the main difference
pharma tariffs on global drug supply chains, manufacturing onshoring investments, and digital IT strategy for compliance.
Whether adding cagrilintide preserves more lean mass than retatrutide alone or whether the added satiety drives more lean-mass loss by reducing protein intake further is unknown
Sleep disruption, a concern for some tirzepatide users dealing with insomnia , does not appear to worsen with retatrutide
